Navigation Links
Hypertension Not Given Priority during Treatment

According to a study it was found that physicians do not change the treatment for patients suffering from uncontrolled hypertension//. But it is also found that hypertension leads to cardiovascular risks.

The findings were presented in New York City at the 21st Annual Scientific Meeting of the American Society of Hypertension (ASH 2006) for the CONTROL PROJECT study group by Dr. Antonio Coca of the Hypertension Unit at the Hospital Clinic of the University Of Barcelona, Spain. ‘The results show that there is a significant lack of concern among primary care physicians about the importance of hypertension treatment in patients at high risk of cardiovascular disease,’ he said.

The CONTROL PROJECT was a cross-sectional, national multi-center study in Spain that followed 1,413 patients with treated and uncontrolled hypertension seen by 356 primary care physicians. The patients, just over half of them women (55.2%), with a mean age of just over 65, were assessed according to European Society of Hypertension 2003 guidelines.

A majority of them were judged to be at either very high (34.5%) or high (29.4%) cardiovascular risk, with a high prevalence of associated cardiovascular risk factors such as overweight (53.7%), hyperlipidemia (52.2%), diabetes (39.5%) and family history of cardiovascular disease (15.7%). In addition, one-fifth of the patients (20.3%) had left ventricular hypertrophy (enlarged hearts) and more than one-in-ten (12.8%) had microalbuminuria, an indicator of subclinical cardiovascular disease.

Despite having blood pressure that was not controlled with treatment (blood pressure higher than 140/90 mmHg or higher than 130/80 mmHg in diabetics), 41.6% of the patients were still treated with just a single antihypertensive drug, and less than half of their primary care physicians (45%) recommended a change in their treatment, either increasing the dose of the single drug being taken (17.55%) or adding an additional drug an d/or prescribing a fixed combination compound (35%). Nearly one-in-three of the primary care physicians (30%) considered that no change was required, and nearly two-thirds (65%) suggested improving compliance to non-pharmacological changes such as diet and exercise. And, only about half (56%) of the physicians asked patients to come in for a new control visit within 2-3 weeks.

Source: Newswise
'"/>




Related medicine news :

1. New viewpoint on Hypertension
2. Hypertension drugs could lower Disability
3. FDA Approves Remodulin for Pulmonary Hypertension
4. Glaucoma & Ocular Hypertension more likely in patients with refractive errors
5. Hypertension lowered by Bedtime Dosing
6. Better Treatment For Hypertension
7. Treating Pulmonary Arterial Hypertension In Children With Viagra
8. Hypertension Drug of Choice for African Americans
9. Hypertension can be caused by Inhalation of Salt
10. Inhaling Salt Can Lead To Hypertension
11. Elderly Women Remain At Risk From Hypertension
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... ... and clinical outcomes, today released the podcast, “Make Plans for MACRA,” ... value-based payment into the physician's office and how physicians and other clinicians are ...
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, president ... honored by Enterprising Women magazine as one of its 2017 Enterprising Women of ... owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively support ...
(Date:4/26/2017)... JOHYNSTON, Iowa (PRWEB) , ... April 26, 2017 ... ... agriculture? DuPont Pioneer today launched a unique website ( CRISPRCas.pioneer.com ) that demonstrates ... plants and help farmers produce more and better food, with fewer resources. It ...
(Date:4/25/2017)... San Jose, CA (PRWEB) , ... April 25, ... ... in cross-screen access, support, and collaboration, announces Mirroring360 Pro . This new ... providing a comprehensive collaboration experience for education and business. , Mirroring360 Pro enables ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report from the ... for the 2015-16 school year across Wisconsin’s public schools, charter schools, and private ... patterns in student test score performance, the report’s limited analyses fail to provide ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment is ... period The Cardiology Devices segment is likely to ... 15 Mn in 2018 over 2017. By the end of ... valuation close to US$ 700 Mn, expanding at a CAGR ... dominated the Asia Pacific reprocessed medical ...
Breaking Medicine Technology: